<DOC>
	<DOCNO>NCT02917967</DOCNO>
	<brief_summary>This longitudinal , prospective , open-label interventional study single center . We investigate effect single injection patient . This study design establish clinical evidence effect botulinum toxin type ( Dysport , abobotulinum toxin A ) injection change musculotendinous length dynamic hamstring muscle gait child spastic cerebral palsy walk excessive knee flexion . Baseline data Modified Ashworth scale ( MAS ) , Modified Tardieu scale ( MTS ) , Gross Motor Function Measures ( GMFM ) , Gross Motor Function Classification System ( GMFCS ) level assess . Gait analysis perform use computerized gait analysis system ( VICON MX-T10 System 6 infrared camera , Oxford Metrics Inc. , Oxford , UK ) measure kinematic data ( angle joint ) gait cycle . A trained investigator place 14 reflective marker anterior posterior superior iliac spine , mid point lateral femur , lateral knee joint axis , midpoint lateral tibia , lateral malleolus , dorsal foot metatarsal head 2 3 . All subject walk barefoot self-selected speed along 8-meter path marker place motion capture 100-Hz sampling frequency . Force-plates ( AMTI OR 6-5 , Advanced Mechanical Technology , Newton , MA , USA ) path record ground reaction force walk trial 1000-Hz sampling frequency , joint moment express internal moment counter ground reaction force . Data collection continue subject achieve least 3 'clean ' force-plate strike . Kinematic kinetic data successful trial use statistical analysis . Video record do simultaneously front , rear , side , 3D gait analysis .</brief_summary>
	<brief_title>A Pilot Study Effect Botulinum Toxin Type ( Dysport® , Abobotulinum Toxin A ) Injection Changes Musculotendinous Length Dynamics Hamstring Muscles During Gait Children With Spastic Cerebral Palsy Walking With Excessive Knee Flexion</brief_title>
	<detailed_description>Based evaluation include gait analysis , select target muscle inject toxin select muscle spastic low limb guidance ultrasonography electrical stimulation . After BoNT-A injection , child evaluate 1 month . Clinical data obtain baseline measurement assess . Motion capture data also collect . Finally , clinical data patient collect 4 month injection identify clinical improvement side effect . Motion capture data import OpenSim . We generate inverse kinematic analysis subject use following procedure : 1 . Scale model match anthropometry subject . We scale dimension torso , pelvis , thigh , shank , foot base relative distance pair marker measure experimentally correspond marker model . The muscle attachment also scale segment . 2 . Using least-squares formulation , set desire joint angle track , consistent scale model , base marker trajectory , joint constraint , joint angle gait analysis compute . 3 . The musculotendinous length muscle calculate base `` low limb model 2010 '' Arnold . This model adopt wrap surface calculate moment arm musculotendinous unit passage joint . This model intend use research-graded kinematic analysis . - Objectives &lt; Primary objective &gt; 1.To determine change musculotendinous length hamstring single BoNT-A injection walk child spastic CP walk excessive knee flexion &lt; Secondary objectives &gt; 1 . To determine efficacy gross motor function BoNT-A injection 2 . To determine benefit gait BoNT-A injection 3 . To determine efficacy spasticity BoNT-A injection 4 . To determine kinematic change BoNT-A injection 5 . To determine dynamic change BoNT-A injection 6 . To determine treatment emergent adverse event follow BoNT-A injection - Subjects : total 32 child cerebral palsy - Intervention : 1 . BoNT-A injected two hamstring and/or gastrocnemius muscle guidance ultrasonography electrical stimulation . 2 . Maximal total dose dose regimen muscle would follow recommendation international consensus . A. Semitendinosus 5 7.5 units/kg body weight B. Semimembranosus 5 7.5 units/kg body weight C. Gastrocnemius 10 units/kg body weight D. Maximal total dose per patient : unilateral injection 500 unit , bilateral injection 1,000 unit E. The dosage two hamstring muscle depend severity spasticity gait abnormality child CP - Studies : 3D motion analysis , GMFM ( gross motor function measure ) , GMFCS ( gross motor function classification system ) , MAS ( modify Ashworth scale ) , MTS ( modify Tardieu scale ) - Evaluation plan : 1 ) pre-intervention , 2 ) post-4 week intervention , 3 ) 16 week intervention</detailed_description>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Children CP age 2 year The spasticity think interfere motor learning cause abnormal posture movement pattern `` management algorithm '' international consensus . 1 . MAS ≥ 1+ hamstring 2 . Dynamic spasticity rather fixed contracture : Difference Xv1 Xv3 least 15 degree MTS hamstring I III level GMFCS Children receive intervention chemical nerve block cast within 6 month Children baclofen pump Children experience adverse reaction previous BoNTA injection Children mix type CP ( Athetosis , dystonia ) movement disorder ( eg . ataxia ) Children participate investigational study moment Children suitable study accord investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>